🇺🇸 FDA
Patent

US 11453870

Ligase fusion proteins and application thereof

granted A61KA61K47/60A61K47/6801

Quick answer

US patent 11453870 (Ligase fusion proteins and application thereof) held by GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K47/60, A61K47/6801, A61K47/68033, A61K47/6817